Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs GH✓SelectedUSD · GHMRNA vs GH performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs GH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+948.4%
GH return
+214.3%
Excess return
+734.1%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGHExcessAlpha
1D-2.2%+0.2%-2.3%-2.2%
7D-12.7%-3.9%-8.8%-11.8%
30D-20.7%-12.5%-8.2%-17.8%
3M+46.3%-13.1%+59.4%+52.2%
6M+305.2%+26.8%+278.4%+283.7%
YTD+561.2%+42.8%+518.5%+503.0%
1Y+772.1%+45.4%+726.7%+690.3%
3Y+147.0%+510.2%-363.2%+47.3%
5Y-26.1%+49.4%-75.5%-44.1%
All+948.4%+214.3%+734.1%+561.4%

Cumulative growth

Daily Returns

Daily percentage return beside GH.

Daily Out/Under-Performance

Portfolio return minus GH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling